Literature DB >> 24354718

Characteristics and performance of minority-serving dialysis facilities.

Yoshio N Hall1, Ping Xu, Glenn M Chertow, Jonathan Himmelfarb.   

Abstract

OBJECTIVE: To examine the structure, processes, and outcomes of American dialysis facilities that predominantly treat racial-ethnic minority patients. DATA SOURCES/STUDY
SETTING: Secondary analysis of data from all patients who initiated dialysis during 2005-2008 in the United States. STUDY
DESIGN: In this retrospective cohort study, we examined the associations of the racial-ethnic composition of the dialysis facility with facility-level survival and achievement of performance targets for anemia and dialysis adequacy. DATA COLLECTION/EXTRACTION
METHODS: We obtained dialysis facility- and patient-level data from the national data registry of patients with end-stage renal disease. We linked these data with clinical performance measures from the Centers for Medicare and Medicaid Services. PRINCIPAL
FINDINGS: Overall, minority-serving facilities were markedly larger, more often community based, and less likely to offer home dialysis than facilities serving predominantly white patients. A significantly higher proportion of minority-serving dialysis facilities exhibited worse than expected survival as compared with facilities serving predominantly white patients (p < .001 for each). However, clinical performance measures for anemia and dialysis adequacy were similar across minority-serving status.
CONCLUSIONS: While minority-serving facilities generally met dialysis performance targets mandated by Medicare, they exhibited worse than expected patient survival. © Health Research and Educational Trust.

Entities:  

Keywords:  Disparities; dialysis facility; end-stage renal disease; race

Mesh:

Year:  2013        PMID: 24354718      PMCID: PMC4024357          DOI: 10.1111/1475-6773.12144

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  40 in total

1.  Performance measurement in search of a path.

Authors:  Rodney A Hayward
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

2.  Neighborhood poverty and racial differences in ESRD incidence.

Authors:  Nataliya Volkova; William McClellan; Mitchel Klein; Dana Flanders; David Kleinbaum; J Michael Soucie; Rodney Presley
Journal:  J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 10.121

3.  Imperial or empirical measures of dialysis quality?

Authors:  Klemens B Meyer; Dana C Miskulin
Journal:  Am J Kidney Dis       Date:  2007-11       Impact factor: 8.860

4.  Separate and unequal: clinics where minority and nonminority patients receive primary care.

Authors:  Anita B Varkey; Linda Baier Manwell; Eric S Williams; Said A Ibrahim; Roger L Brown; James A Bobula; Barbara A Horner-Ibler; Mark D Schwartz; Thomas R Konrad; Jacqueline C Wiltshire; Mark Linzer
Journal:  Arch Intern Med       Date:  2009-02-09

5.  Cost, quality, and value: the changing political economy of dialysis care.

Authors:  Jonathan Himmelfarb; Arnold Berns; Lynda Szczech; Donald Wesson
Journal:  J Am Soc Nephrol       Date:  2007-06-13       Impact factor: 10.121

6.  Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis.

Authors:  Michael V Rocco; Diane L Frankenfield; Sari D Hopson; William M McClellan
Journal:  Ann Intern Med       Date:  2006-10-03       Impact factor: 25.391

7.  Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes.

Authors:  Rudolph A Rodriguez; Saunak Sen; Kala Mehta; Sandra Moody-Ayers; Peter Bacchetti; Ann M O'Hare
Journal:  Ann Intern Med       Date:  2007-04-03       Impact factor: 25.391

8.  Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD.

Authors:  Yoshio N Hall; Jared G Sugihara; Alan S Go; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2005-10-19       Impact factor: 10.121

9.  Concentration and quality of hospitals that care for elderly black patients.

Authors:  Ashish K Jha; E John Orav; Zhonghe Li; Arnold M Epstein
Journal:  Arch Intern Med       Date:  2007-06-11

10.  Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care?

Authors:  Michael M Ward
Journal:  Arch Intern Med       Date:  2007-05-28
View more
  6 in total

Review 1.  Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society.

Authors:  Keith C Norris; Sandra F Williams; Connie M Rhee; Susanne B Nicholas; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; L Ebony Boulware
Journal:  Semin Dial       Date:  2017-03-09       Impact factor: 3.455

2.  Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States.

Authors:  Rajnish Mehrotra; Melissa Soohoo; Matthew B Rivara; Jonathan Himmelfarb; Alfred K Cheung; Onyebuchi A Arah; Allen R Nissenson; Vanessa Ravel; Elani Streja; Sooraj Kuttykrishnan; Ronit Katz; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2015-12-10       Impact factor: 10.121

3.  Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients.

Authors:  Tanya S Johns; Michelle M Estrella; Deidra C Crews; Lawrence J Appel; Cheryl A M Anderson; Patti L Ephraim; Courtney Cook; L Ebony Boulware
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

Review 4.  Disparities in the burden, outcomes, and care of chronic kidney disease.

Authors:  Deidra C Crews; Yang Liu; L Ebony Boulware
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

5.  Toward Antiracist Reimbursement Policy in End-Stage Kidney Disease: From Equality to Equity.

Authors:  Kathryn Taylor; Deidra C Crews
Journal:  J Am Soc Nephrol       Date:  2021-07-12       Impact factor: 14.978

6.  Area-level poverty, race/ethnicity & dialysis star ratings.

Authors:  Abhijit V Kshirsagar; Raj N Manickam; Yi Mu; Jennifer E Flythe; Andrew I Chin; Heejung Bang
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.